November 2009

More recent posts

Byte-sized roundup

27/11/09 permalink ABPI joins Twitter, illegal drug websites taken down, Digital Economy Bill lined up and Digital Media Pioneer nominations close soon.

The ABPI this week became the latest pharma industry body to launch an official Twitter account, @ABPI_APS. (Read more)

AstraZeneca joins the blogosphere

26/11/09 permalink AZ takes stock of its first month of blogging and looks at what the medium holds for 'healthcare engagement'.

AstraZeneca recently launched its first official corporate blog, joining the likes of Johnson & Johnson and GlaxoSmithKline on the blogosphere. (Read more)

Byte-sized roundup

20/11/09 permalink Includes LinkedIn gets linked up and London's gets new electronic patient records.

LinkedIn and Microsoft have signed a deal that will see the forthcoming version of Outlook incorporate feeds from the social networking platform. (Read more)

Reacting to sidewiki

18/11/09 permalink AstraZeneca becomes the first pharma company to address the threat of Google's internet-wide comment tool.

Over the last two months pharmaceutical company websites have been plagued by unwanted, un-moderated comments thanks to Google's sidewiki. (Read more)

FDA listens on social media

16/11/09 permalink The dust starts to settle from round one of the FDA's social media and internet hearing, but the process is far from over.

The FDA's last internet-related hearing took place more than ten years ago in 1996, a time when its concerns centred around chat-rooms, newsgroups and website links. (Read more)

Digital Pharma: Byte-sized roundup

18/11/09 permalink Includes: FDA social media hearing, Solvay's Russian Twitter account and Google's UK ad regulation role.

Solvay Pharma has joined the ranks of pharma companies using Twitter, setting up a Russian language account for its Moscow-based subsidiary. (Read more)

Counting down to the FDA's social media hearing

18/11/09 permalink The US regulator will this week give pharma's internet use more attention than at any time in the last decade.

Later this week the FDA will hold its hotly anticipated hearing on pharma's use of social media. (Read more)

Pfizer's multi-media dead rat

04/11/09 permalink Pfizer has given a multi-media boost to its hard-hitting 'dead rat' campaign, which warns about the dangers of buying counterfeit medicines.

First launched as cinema adverts at the beginning of this year, the campaign hit the small screen last night when it was shown on UK television for the first time. (Read more)

Older posts